MedTrace Logo

Good Schools Study

NCT01678846 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3820

Last updated 2016-01-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether use of the Good Schools Toolkit is effective in reducing violence against children in primary schools.

Conditions

  • Physical Violence
  • Educational Achievement
  • Mental Health
  • Sexual Violence
  • Violence Against Children

Interventions

BEHAVIORAL

Good School Toolkit

The Toolkit uses a six step process to create a school wide intervention that engages teachers, students, administration, and parents to reflect on how they can promote quality of education in their school. The Toolkit articulates complex ideas (what is a good learning environment, a good teacher, how to create positive discipline without using violence) through booklets, posters and school initiated learning processes. Specific modules on alternative discipline techniques and how staff can use positive discipline are included in the Toolkit. The intervention includes sessions on knowledge, attitudes and opportunities to practice new behavioural skills. Work is led by teachers and students, and supported by visits from Raising Voices staff. The Toolkit can be reviewed at (http://www.raisingvoices.org/children/good\_school\_toolkit.php).

Sponsors & Collaborators

  • Raising Voices

    collaborator OTHER

  • Institute of Education, UK

    collaborator UNKNOWN

  • Makerere University

    collaborator OTHER

  • London School of Hygiene and Tropical Medicine

    lead OTHER

Principal Investigators

  • Karen M Devries, PhD · London School of Hygiene and Tropical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Uganda

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01678846 on ClinicalTrials.gov